Health  Vol.9 No.3 , March 2017
A Preliminary Study of Age and Sex of People with Hemophilia
Abstract: Aim: This paper aims at providing more information of people with hemophilia for more targeted treatment. Methods: 1149 people with hemophilia are surveyed in 45 units, and then established by EpiData software. The number of people with hemophilia in 9 age intervals for the male and female is analyzed by Population Pyramid and Pareto Analysis. Results: It is found that the people with hemophilia are appearing in every age interval. Relative to the number of male patients, the number of female patients is extremely rare. Of 1134 male patients, relative frequencies for male ranked the first (23.0%), second (17.4%), third (17.2%) are 7 - 12, 2 - 3, 13 - 18 years old, respectively, while of 15 female patients, relative frequencies for female in these age intervals are only 13.3%, 13.3%, 6.7%, respectively. However, the most relative frequency of female patients is between 26 - 45 years old. Conclusion: There is a challenge of the aging hemophilia population. Most of male patients are between 7 - 12 and 2 - 3 years old. Most of female patients are between 26 - 45 years old.
Keywords: Hemophilia, Survey, Age, Sex
Cite this paper: Yang, S. , Ge, M. , Liu, S. , Liu, Y. , Cen, M. and Pan, C. (2017) A Preliminary Study of Age and Sex of People with Hemophilia. Health, 9, 401-408. doi: 10.4236/health.2017.93028.

[1]   Ingram, G.I. (1976) The History of Haemophilia. Journal of Clinical Pathology, 29, 469-479.

[2]   Smit, C., Rosendaal, F.R., Varekamp, I., Bröcker-Vriends, A., et al. (1989) Physical Condition, Longevity, and Social Performance of Dutch Haemophiliacs. British Medical Journal, 298, 235-238.

[3]   Berntorp, E. and Shapiro, A.D. (2012) Modern Haemophilia Care. The Lancet, 379, 1447-1456.

[4]   Schramm, W. (2014) The History of Haemophilia—A Short Review. Thrombosis Research, 134, S4-S9.

[5]   Mannucci, P.M. (2002) Hemophilia and Related Bleeding Disorders: A Story of Dismay and Success. In: American Society of Hematology Education Program, Hematology. American Society of Hematology. Education Program, The Society, Washington DC, 1-9.

[6]   James, A.H. (2010) Women and Bleeding Disorders. Hemophilia, 16, 160-167.

[7]   Franchini, M. and Mannucci, P.M. (2012) Past, Present and Future of Hemophilia: A Narrative Review. Orphanet Journal of Rare Diseases, 7, 24.

[8]   Rhynders, P.A., Sayers, C.A., Presley, R.J. and Thierry, J.M. (2014) Providing Young Women with Credible Health Information about Bleeding Disorders. American Journal of Preventive Medicine, 47, 674-680.

[9]   Hermans, C., de Moerloose, P. and Dolan, G. (2014) Clinical Management of Older Persons with Haemophilia. Critical Reviews in Oncology/Hematology, 89, 197-206.

[10]   Myrin-Westesson, L., Baghaei, F. and Friberg, F. (2013) The Experience of Being a Female Carrier of Haemophilia and the Mother of a Haemophilic Child. Haemophilia, 19, 219-224.

[11]   Holstein, K., Eifrig, B. and Langer, F. (2014) Relationship between Haemophilia and Social Status. Thrombosis Research, 134, S53-S56.

[12]   Dai, J., Lu, Y., Ding, Q., Wang, H., Xi, X. and Wang, X. (2012) The Status of Carrier and Prenatal Diagnosis of Haemophilia in China. Haemophilia, 18, 235-240.

[13]   Bastani, P., Pourmohamadi, K. and Karimi, M. (2012) Quality of Life in Hemophilia Complicated by Inhibitors. Iranian Red Crescent Medical Journal, 14, 250-251.

[14]   Liu, Y. and Chen, L. (2011) Correlation between Quality of Life and Joint Health in Children with Haemophilia. Chinese Journal of Rehabilitation, 26, 112-114. (In Chinese)

[15]   James, A.H., Ragni, M.V. and Picozzi, V.J. (2006) Bleeding Disorders in Premenopausal Women: (Another) Public Health Crisis for Hematology? ASH Education Book, 2006, 474-485.

[16]   Zhang, N., Peng, Y., Wu, R., et al. (2013) Value of International Prophylaxis Study Group (IPSG) Magnetic Resonance Imaging Scale System in the Evaluation of Hemophiliac Arthropathy Joint Changes in Children. Journal of Capital Medical University, 34, 342-347. (In Chinese)

[17]   Lauritsen, J.M. and Bruus, M. (2003) EpiData (Version 3). A Comprehensive Tool for Validated Entry and Documentation of Data. The EpiData Association, Odense.

[18]   Li, Z. and Luo, P. (2011) PASWSPSS Statistics Course in Chinese Version (Version 3). Publishing House of Electronics Industry, Beijing.

[19]   Bolton-Maggs, P.H. and Pasi, K.J. (2003) Hemophilias A and B. The Lancet, 361, 1801-1809.

[20]   Darby, S.C., Kan, S.W., Spooner, R.J., Giangrande, P.L., et al. (2007) Mortality Rates, Life Expectancy, and Causes of Death in People with Hemophilia A or B in the United Kingdom Who Were Not Infected with HIV. Blood, 110, 815-825.

[21]   Zimmermann, R., Staritz, P. and Huth-Kühne, A. (2014) Challenges in Treating Elderly Patients with Haemophilia A Focus on Cardiology. Thrombosis Research, 134, S48-S52.

[22]   James, A.H. (2005) More Than Menorrhagia: A Review of the Obstetric and Gynae-cological Manifestations of Bleeding Disorders. Haemophilia, 11, 295-307.

[23]   Byams, V.R. (2007) Women with Bleeding Disorders. Journal of Women’s Health, 16, 1249-1251.

[24]   Sylvia, R., Werner, S., Thomas, S., Florian, W., et al. (2009) Austrian Hemophilia Registry: Design, Development and Set of Variables. The Middle European Journal of Medicine, 121, 196-201.

[25]   Murray, C.J.L., Ortblad, K.F., Guinovart, C., Lim, S.S., et al. (2014) Global, Regional, and National Incidence and Mortality for HIV, Tuberculosis, and Malaria during 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 1005-1070.

[26]   Uguen, D., Lönngren, T., Le Cam, Y., Garner, S., et al. (2014) Accelerating Development, Registration and Access to Medicines for Rare Diseases in the European Union through Adaptive Approaches: Features and Perspectives. Orphanet Journal of Rare Diseases, 9, 20.